Lag 3 inhibitors are shaping up as the next big thing. trials have shown that in combination with PD1 inhibitors they improve efficacy alot. That combination efficacy looks like being the new benchmark. Should we get ahead of the curve and have a pd1/lag3/fto inhibitor vs pd1/lag3 trial in the mix? BP is looking at LAG 3 as the next big thing. If you have trials with LAG 3 in the mix it will help zantrene catch the attention of BP and just seems like a good idea. thoughts? somebody float this with Dr T please.
- Forums
- General
- General Comments / Chat
Lag 3 inhibitors are shaping up as the next big thing. trials...
-
-
- There are more pages in this discussion • 6,040 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.84 |
Change
0.080(4.56%) |
Mkt cap ! $312.7M |
Open | High | Low | Value | Volume |
$1.76 | $1.86 | $1.76 | $464.9K | 258.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.86 | 4243 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | 1.835 |
1 | 25000 | 1.815 |
1 | 10000 | 1.800 |
1 | 8516 | 1.790 |
1 | 190 | 1.785 |
Price($) | Vol. | No. |
---|---|---|
1.860 | 4243 | 1 |
1.865 | 2690 | 1 |
1.880 | 866 | 1 |
1.890 | 6000 | 2 |
1.900 | 8590 | 3 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online